Call for Sponsors and Exhibitors
Space available for exhibitors is very limited and we expect it to be heavily oversubscribed. So please contact us as soon as possible to receive information about exhibition & sponsorship opportunities:
Ian Slade
Tel: 203-926-1400
E-mail: ian.slade@selectbiosciences.com
Corporate Sponsors
BD Biosciences
BD Biosciences, a segment of BD, is one of the world’s leading businesses focused on bringing innovative research and clinical tools to life scientists and clinicians. Its product lines include: flow cytometers; cell imaging systems; monoclonal antibodies; research reagents; diagnostics assays; and tools to help grow tissue and cells.
Invitrogen
Invitrogen Corporation provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's R&D efforts are focused on breakthrough innovation in biological discovery including stem cell science – its products are referenced in a 100% of the most cited stem cell research papers. For more information, visit www.invitrogen.com/stemcell
Millipore
Global scientific advancements in biomedical and academic research laboratories are aided by Millipore’s innovative biological reagents. Millipore improves productivity by offering kits, tools, reagents and cell lines for applications such as stem cell, cell signaling and diagnostics research. Millipore is a leading provider of mouse embryonic stem cells and reagents as well as human adult and primary cells that are used to foster growth and discovery for disease treatment and development.
Exhibitors
Amaxa
Amaxa develops and commercializes innovative products for the transfer of DNA or siRNA into cells. Its unique Nucleofector® technology provides a breakthrough tool for the highly efficient, non-viral transfection of primary cells and hard-to-transfect cell lines, enabling researchers to now use primary cells in their gene transfer experiments in basic research and drug development. The recently introduced Nucleofector® 96-well-Shuttle® System now also allows high throughput transfection in 96-well format.
BioE 
BioE is a biomedical company providing human cord blood stem cells as enabling, high-quality cellular tools for drug discovery and therapeutic research. The company’s novel Multi-Lineage Progenitor Cell™ (MLPC™) is a genetically normal, multi-potent, clonal cell derived from human umbilical cord blood and obtained using PrepaCyte®, the company’s proprietary cell isolation platform. The MLPC™ provides clinicians and researchers a flexible, long-term and non-controversial tool for therapeutic research, drug discovery, and screening.
BioSpherix
ULTIMATE STEM CELL WORKSTATION, an advanced new incubation system. Multiple independent high performance O2/CO2/NO/CO incubators offer unprecedented new ability to manipulate stem cell phenotype. Integrated inside matching aseptic O2/CO2/NO/CO controlled-atmosphere isolators along with microscopes, sorters, centrifuges, etc., this unique system provides the first economical and practical alternative to cleanrooms for GMP-compliant production of stem cells for therapy.
Cell Signaling Technology
Cell Signaling Technology (CST), the innovator in activation-state antibodies and related technologies, provides the highest quality reagents necessary to identify stem cells and elucidate signal transduction pathways involved in stem cell maintenance and differentiation. All CST antibodies are produced in-house and validated in applications including immunofluorescence, immunohistochemistry and flow cytometry. Moreover, technical support is provided by the same scientists who produce the product and know it best.
Celprogen 
Celprogen provides Stem Cell and Cell Biology products for Life Sciences, Pharmaceutical drug discovery and Diagnostics industries. Celprogen’s products are available as complete primary & established tissue culture system kits. Celprogen provides adult and embryonic Stem Cells with specific cell based assays for molecular diagnostics and therapeutics applications. Celprogen’s major organ system kits provide an excellent choice for drug discovery and pharmaceutical toxicology studies, for more product information visit www.celprogen.com.
Cognate Bioservices
Cognate BioServices, Inc. was formed to provide full commercialization support to companies developing varied cellular technologies, encountering translational challenges in development, manufacturing, quality, regulatory and delivery. The expertise of the management team and staff provides a cost-effective solution to the need in the current market for early focus on product development and clinical phase planning, without the need for extensive capital outlay.
Miltenyi Biotec
Miltenyi Biotec provides products and services for pursuing life science research. Based on MACS® Technology, the portfolio includes over 600 products for the separation, cultivation, flow cytometric and molecular analysis of cells. The MACSmolecular business unit offers innovative solutions for molecular biology research, comprehensive microarray service, and microarray hybridization instrumentation.
Sigma-Aldrich
Sigma-Aldrich supplies the most complete line of high-quality, high-performance cell culture products in the industry. We offer a broad selection of media, sera, reagents, and analytical kits that span the needs of basic research applications as well as cGMP-compliant large-scale biopharmaceutical production. Included in these products is our new and expanding line of StemlineTM media products, designed for adult stem cell applications.
Stem Cell Innovations
SCI is a cell biology company with facilities in Scotch Plains, N.J., Houston, TX and in Leiden, the Netherlands. Stem Cell Innovations proprietary, human pluripotent stem cells, known as PluriCells, have the potential to aid in drug discovery, toxicology, and cell therapy. Stem Cell Innovations is in the process of making its patented pluripotent cell lines, which are eligible for federal funding in the U.S., widely available to universities and other not-for-profit institutions to rapidly advance stem cell research. Stem Cell Innovations is positioned to become a leading provider of toxicology testing and discovery systems for the pharmaceutical, chemical, and nutraceutical industries around the world. The development of the proprietary PluriCell technology greatly expands the Company’s currently marketed C3A human liver cell-based toxicology offerings. Additional information is available at www.stemcellinnovations.com.